Get the Stockscreener App
3.03
3.41%
0.10
After Hours:
3.13
0.10
+3.30%
Firefly Neuroscience Inc stock is traded at $3.03, with a volume of 47,215.
It is up +3.41% in the last 24 hours and up +2.71% over the past month.
Firefly Neuroscience Inc is an AI company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support better outcomes for people suffering from mental illnesses and cognitive disorders.
See More
Previous Close:
$2.93
Open:
$2.99
24h Volume:
47,215
Relative Volume:
0.24
Market Cap:
$25.33M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-12.68%
1M Performance:
+2.71%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$2.8501
$3.06
1-Week Range:
$2.8501
$3.50
52-Week Range:
$2.74
$8.50
Firefly Neuroscience Inc Stock (AIFF) Company Profile
Name
Firefly Neuroscience Inc
Sector
Industry
Phone
(703) 383-3000
Address
12015 LEE JACKSON MEMORIAL HWY, FAIRFAX
Firefly Neuroscience Inc Stock (AIFF) Latest News
Arbor Realty Trust Schedules Third Quarter 2024 Earnings Conference Call - ForexTV.com
Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Bright Minds and Firefly Neuroscience Renew Collaboration - TipRanks
What's Going On With Bright Minds Biosciences Stock? - Benzinga
Bright Minds, Firefly Neuroscience Shares Rise on Collaboration for Clinical Trial Analysis - MarketWatch
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Bright Minds, Firefly Neuroscience to collaborate after BREAKTHROUGH study - TipRanks
Atossa Therapeutics to Participate in Fireside Chat with Karolinska Institute at BIO-EUROPE 2024 to Discuss a Unique Swedish American Collaboration to Prevent Breast Cancer - The Manila Times
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data - ForexTV.com
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Manhattan Associates (MANH) Stock Dips 1.52% Amid Broader Softwa - GuruFocus.com
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysis - Benzinga
Firefly and Bright Minds collaborate on brain health AI - Investing.com India
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views - Benzinga
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results - MSN
Firefly and Bright Minds collaborate on brain health AI By Investing.com - Investing.com South Africa
Firefly Neuroscience, Bright Minds collaborate to analyze study data on BMB-101 - TipRanks
Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology - The Manila Times
Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder - The Manila Times
Firefly Neuroscience to Participate in Upcoming October Investor Conferences - EIN News
Firefly Neuroscience, Zeto Agree To EEG Headset Distribution Deal - MPO-mag
AIFF stock touches 52-week low at $2.74 amid market challenges - Investing.com Australia
AIFF stock touches 52-week low at $2.74 amid market challenges By Investing.com - Investing.com South Africa
AIFF Stock Hits 52-Week Low at $2.99 Amid Market Challenges - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.62% - Investing.com
Strategic Announcement Drove Firefly (AIFF) Stock After-Hour - Stocks Telegraph
Firefly partners with pharma giants to enhance drug development - Investing.com
Firefly partners with pharma giants to enhance drug development By Investing.com - Investing.com Canada
Firefly Neuroscience Advances AI-Driven BNA™ Technology in Neuroscience Drug Development after Completing - EIN News
Butterfly Network retains Buy rating from TD Cowen with steady price target By Investing.com - Investing.com South Africa
SPAC firms: Stem Inc CEO steps down, Energy Vault warned over share price - Energy-Storage.news
Butterfly Network Inc [BFLY] Insider Activity: An Update for Investors - Knox Daily
A multibillion-dollar project, Firefly Park, sets opening date in Frisco - WFAA.com
Quest Partners LLC Acquires New Stake in Freshpet, Inc. (NASDAQ:FRPT) - Defense World
Firefly and Zeto team up to distribute EEG headset devices - Yahoo Finance
AIFF stock touches 52-week low at $3.12 amid market challenges - Investing.com
Global IoT in Banking And Financial Services Market Size To Worth USD 38.52 Billion By 2033 | CAGR of 40.67% - FinTech Futures
Firefly Neuroscience adds pharma veteran to board - Investing.com
Top Aces Integrates Cutting-Edge IRST on F-16 Advanced Aggressor Fighter - Digital Journal
Firefly Neuroscience adds pharma veteran to board By Investing.com - Investing.com UK
Firefly Neuroscience Inc Stock (AIFF) Financials Data
There is no financial data for Firefly Neuroscience Inc (AIFF). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):